Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma

Inflammatory Arthritis Induced by Pembrolizumab in a Patient With Head and Neck Squamous Cell Carcinoma

Introduction: T cell checkpoint inhibitors targeting Programmed cell Death protein-1 (PD-1) have emerged as novel immunotherapy agents showing remarkable efficacy in head and neck squamous cell carcinoma (HNSCC). Despite important clinical benefits, they are associated with side effects that occur a...

Full description

Bibliographic Details
Main Authors: Nikolaos Spathas, Panagiota Economopoulou, Myrto Cheila, Ioannis Kotsantis, Antonis Fanouriakis, Dimitra Kassara, Amanda Psyrri
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-09-01
Series:Frontiers in Oncology
Subjects:
pembrolizumab
inflammatory arthritis
head and neck cancer
immune checkpoint inhibitors
immune-related adverse events
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2018.00409/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2018.00409/full

Similar Items